Cost-based COVID-19 vaccination and willingness to pay: A post-pandemic review

Cost-based COVID-19 vaccination and willingness to pay: A post-pandemic review

Blog Article

The primary objective of this paper is to serve as a valuable resource for policymakers who are confronted Decor with the evolving landscape of the coronavirus disease 2019 (COVID-19), considering both free and cost-based vaccination approaches.The potential consequences of shifting from free to cost-based vaccination are explored, encompassing its impact on global vaccine equity and prioritization, economic well-being, healthcare systems and delivery, public health policies, and vaccine distribution strategies.Examining past studies on willingness to pay for the initial COVID-19 vaccine dose and booster shots provides insights into how individuals value COVID-19 vaccinations and underscores the significance of addressing issues related to affordability.If COVID-19 vaccinations incur expenses, using effective Hand Peelers communication strategies that emphasize the importance of vaccination and personal health benefits can increase willingness to pay.

Making COVID-19 vaccines accessible through public health programs or health insurance can help alleviate financial barriers and increase vaccination rates.